Hyperglycemia is a metabolic state characterized by an excess concentration of glucose in the bloodstream, typically defined as a fasting blood glucose level >126 mg/dL or a random blood glucose >200 mg/dL. It results from an absolute or relative deficiency of insulin, insulin resistance, excessive glucose production by the liver, or a combination of these factors. hyperglycemia is the hallmark biochemical feature of diabetes mellitus in all its forms, but can also occur as an acute stress response (stress hyperglycemia), as a medication side effect (e.g., corticosteroids), or in other endocrine disorders. Chronic hyperglycemia damages blood vessels and nerves, leading to micro- and macrovascular complications. Acutely severe hyperglycemia can precipitate life-threatening crises such as diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS).
⚠️ Coding note: R73.9 should be used when hyperglycemia is documented but NOT attributed to a specific type of diabetes. If diabetes is documented, use the appropriate E-code with the .65 subcategory.
🟠 Hyperglycemia with Diabetes Mellitus (Chapter E — Endocrine/Metabolic)
Stress hyperglycemia in a non-diabetic hospitalized patient → R73.9 (not an E-code)
Steroid-induced hyperglycemia progressing to diabetes → E09.65
When both DKA and hyperglycemia are documented → code the DKA (E__.1x); the hyperglycemia is integral — do not code R73.9 additionally
Type 2 DM with HHS is one of the highest-severity presentations → ensure E11.00 or E11.01 is captured as it drives significant MS-DRG weight
E11.65 is among the most frequently under-coded in inpatient charts when providers document “uncontrolled diabetes” — query for specificity: is it hyperglycemia or hypoglycemia?
The ICD-10-CM Excludes1 note on R73.9 excludes diabetes mellitus — if DM is present, an E-code must be used instead
For urology patients: hyperglycemia/diabetes is a critical comorbidity for MS-DRG calculation in nephrolithiasis, UTI, renal failure, and post-op cases — always capture it when documented